As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
Moderna CEO Stéphane Bancel defended ... So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?” The company has said it plans to increase the cost of the vaccine to ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
Moderna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting efforts took hold and sales ...
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.
The U.S. Food & Drug Administration has given its full and final approval for the use of Moderna's 'Spikevax' Covid vaccine ... against this virus," said CEO Stéphane Bancel.
News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...
Do you have questions surrounding COVID-19, the vaccine and impacts on our communities? ABC13 is committed to finding answers and connecting you with resources. Man deliberately gets 217 Covid ...
Mar. 8, 2024 — COVID-19 ... the century-old vaccine reduced tumors and extended survival for mice with liver ... Feb. 20, 2024 — A study has shown that shortly after an increase in ...
The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 ... updated vaccines will be critical to protecting the population this season,” Moderna CEO Stéphane Bancel ...